134 related articles for article (PubMed ID: 33510809)
1. Rutaecarpine Ameliorates Pressure Overload Cardiac Hypertrophy by Suppression of Calcineurin and Angiotensin II.
Li S; Huang B; Zhou C; Shi J; Wu Q; Jiang Q
Evid Based Complement Alternat Med; 2021; 2021():8857329. PubMed ID: 33510809
[TBL] [Abstract][Full Text] [Related]
2. Rutaecarpine prevents hypertensive cardiac hypertrophy involving the inhibition of Nox4-ROS-ADAM17 pathway.
Zeng SY; Yang L; Lu HQ; Yan QJ; Gao L; Qin XP
J Cell Mol Med; 2019 Jun; 23(6):4196-4207. PubMed ID: 30953402
[TBL] [Abstract][Full Text] [Related]
3. A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload.
Grund A; Szaroszyk M; Döppner JK; Malek Mohammadi M; Kattih B; Korf-Klingebiel M; Gigina A; Scherr M; Kensah G; Jara-Avaca M; Gruh I; Martin U; Wollert KC; Gohla A; Katus HA; Müller OJ; Bauersachs J; Heineke J
Cardiovasc Res; 2019 Jan; 115(1):71-82. PubMed ID: 29931050
[TBL] [Abstract][Full Text] [Related]
4. Carabin protects against cardiac hypertrophy by blocking calcineurin, Ras, and Ca2+/calmodulin-dependent protein kinase II signaling.
Bisserier M; Berthouze-Duquesnes M; Breckler M; Tortosa F; Fazal L; de Régibus A; Laurent AC; Varin A; Lucas A; Branchereau M; Marck P; Schickel JN; Deloménie C; Cazorla O; Soulas-Sprauel P; Crozatier B; Morel E; Heymes C; Lezoualc'h F
Circulation; 2015 Jan; 131(4):390-400; discussion 400. PubMed ID: 25369805
[TBL] [Abstract][Full Text] [Related]
5. Calcineurin expression, activation, and function in cardiac pressure-overload hypertrophy.
Lim HW; De Windt LJ; Steinberg L; Taigen T; Witt SA; Kimball TR; Molkentin JD
Circulation; 2000 May; 101(20):2431-7. PubMed ID: 10821822
[TBL] [Abstract][Full Text] [Related]
6. A Reduction in ADAM17 Expression Is Involved in the Protective Effect of the PPAR-
Zeng SY; Lu HQ; Yan QJ; Zou J
PPAR Res; 2018; 2018():7916953. PubMed ID: 30105051
[TBL] [Abstract][Full Text] [Related]
7. Mechanical stress-evoked but angiotensin II-independent activation of angiotensin II type 1 receptor induces cardiac hypertrophy through calcineurin pathway.
Zhou N; Li L; Wu J; Gong H; Niu Y; Sun A; Ge J; Zou Y
Biochem Biophys Res Commun; 2010 Jun; 397(2):263-9. PubMed ID: 20580688
[TBL] [Abstract][Full Text] [Related]
8. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
Zhou N; Ma B; Stoll S; Hays TT; Qiu H
Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247
[TBL] [Abstract][Full Text] [Related]
9. Caveolin-3 Overexpression Attenuates Cardiac Hypertrophy via Inhibition of T-type Ca2+ Current Modulated by Protein Kinase Cα in Cardiomyocytes.
Markandeya YS; Phelan LJ; Woon MT; Keefe AM; Reynolds CR; August BK; Hacker TA; Roth DM; Patel HH; Balijepalli RC
J Biol Chem; 2015 Sep; 290(36):22085-100. PubMed ID: 26170457
[TBL] [Abstract][Full Text] [Related]
10. Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca2+ handling and calcineurin-NFAT signaling pathway.
Ding W; Dong M; Deng J; Yan D; Liu Y; Xu T; Liu J
Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H792-802. PubMed ID: 25015961
[TBL] [Abstract][Full Text] [Related]
11. Progress in Studies on Rutaecarpine. II.--Synthesis and Structure-Biological Activity Relationships.
Son JK; Chang HW; Jahng Y
Molecules; 2015 Jun; 20(6):10800-21. PubMed ID: 26111170
[TBL] [Abstract][Full Text] [Related]
12. Rutaecarpine attenuates hypoxia-induced right ventricular remodeling in rats.
Li WQ; Li XH; Du J; Zhang W; Li D; Xiong XM; Li YJ
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):757-67. PubMed ID: 27052575
[TBL] [Abstract][Full Text] [Related]
13. The renin-angiotensin system and volume overload-induced cardiac hypertrophy in rats. Effects of angiotensin converting enzyme inhibitor versus angiotensin II receptor blocker.
Ruzicka M; Yuan B; Harmsen E; Leenen FH
Circulation; 1993 Mar; 87(3):921-30. PubMed ID: 8443912
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy.
Liu BL; Cheng M; Hu S; Wang S; Wang L; Tu X; Huang CX; Jiang H; Wu G
Biomed Pharmacother; 2018 Dec; 108():1347-1356. PubMed ID: 30372837
[TBL] [Abstract][Full Text] [Related]
15. Evodiamine Inhibits Angiotensin II-Induced Rat Cardiomyocyte Hypertrophy.
He N; Gong QH; Zhang F; Zhang JY; Lin SX; Hou HH; Wu Q; Sun AS
Chin J Integr Med; 2018 May; 24(5):359-365. PubMed ID: 28875323
[TBL] [Abstract][Full Text] [Related]
16. Proteasome inhibition attenuates heart failure during the late stages of pressure overload through alterations in collagen expression.
Ma Y; Chen Y; Yang Y; Chen B; Liu D; Xiong Z; Zhang C; Dong Y
Biochem Pharmacol; 2013 Jan; 85(2):223-33. PubMed ID: 23142711
[TBL] [Abstract][Full Text] [Related]
17. Rutaecarpine: A promising cardiovascular protective alkaloid from Evodia rutaecarpa (Wu Zhu Yu).
Tian KM; Li JJ; Xu SW
Pharmacol Res; 2019 Mar; 141():541-550. PubMed ID: 30616017
[TBL] [Abstract][Full Text] [Related]
18. Role of cardiac renin-angiotensin system in the development of pressure-overload left ventricular hypertrophy in rats with abdominal aortic constriction.
Reddy DS; Singh M; Ghosh S; Ganguly NK
Mol Cell Biochem; 1996 Feb; 155(1):1-11. PubMed ID: 8717433
[TBL] [Abstract][Full Text] [Related]
19. Melatonin protects against the pathological cardiac hypertrophy induced by transverse aortic constriction through activating PGC-1β: In vivo and in vitro studies.
Zhai M; Liu Z; Zhang B; Jing L; Li B; Li K; Chen X; Zhang M; Yu B; Ren K; Yang Y; Yi W; Yang J; Liu J; Yi D; Liang H; Jin Z; Reiter RJ; Duan W; Yu S
J Pineal Res; 2017 Oct; 63(3):. PubMed ID: 28708271
[TBL] [Abstract][Full Text] [Related]
20. Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy.
Shimoyama M; Hayashi D; Takimoto E; Zou Y; Oka T; Uozumi H; Kudoh S; Shibasaki F; Yazaki Y; Nagai R; Komuro I
Circulation; 1999 Dec; 100(24):2449-54. PubMed ID: 10595959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
